文献速递细菌感染、耐药与抗菌药物医院感染防控

抗生素管理对耐药菌感染及定植和艰难梭菌感染发生率的影响:系统综述与荟萃分析

Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis.
PubMed 文献 · Lancet Infect Dis · 2017-06-16

该系统综述与荟萃分析纳入32项研究(共9 056 241患者日、159个发生率估计值),评估抗生素管理项目对住院患者耐药菌感染/定植及艰难梭菌感染发生率的影响。结果显示,抗生素管理显著降低多重耐药革兰阴性菌(降低51%)、产超广谱β-内酰胺酶革兰阴性菌(降低48%)、耐甲氧西林金黄色葡萄球菌(降低37%)及艰难梭菌感染(降低32%)的发生率;与感染控制措施(尤其手卫生)联合实施时效果更佳,但对万古霉素耐药肠球菌及喹诺酮/氨基糖苷类耐药革兰阴性菌无显著影响。

要点

  • 抗生素管理显著降低多重耐药革兰阴性菌、产ESBL革兰阴性菌、MRSA及艰难梭菌感染发生率。
  • 与感染控制措施(尤其手卫生)联合实施时效果优于单独实施。
  • 对万古霉素耐药肠球菌及喹诺酮/氨基糖苷类耐药革兰阴性菌发生率无显著影响。

核心结论

  • 抗生素管理项目显著降低住院患者耐药菌感染和定植及艰难梭菌感染的发生率。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed、Cochrane系统综述数据库、Cochrane对照试验中心注册库及Web of Science(1960年1月1日至2016年5月31日),排除长期照护机构研究,最终纳入32项研究,共9 056 241患者日、159个发生率估计值。

关键数值与推荐

  • 抗生素管理对万古霉素耐药肠球菌及喹诺酮类和氨基糖苷类耐药革兰阴性菌的发生率无显著影响。
  • 研究间存在显著异质性,部分由干预类型和目标细菌共耐药模式解释。

临床怎么用

  • 住院患者中实施抗生素管理项目可降低耐药菌和艰难梭菌感染负担,建议与感染控制措施(尤其手卫生)联合推行。

局限性

  • 研究间存在显著异质性,部分由干预类型和目标细菌共耐药模式解释。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Antibiotic stewardship programmes have been shown to reduce antibiotic use and hospital costs. We aimed to evaluate evidence of the effect of antibiotic stewardship on the incidence of infections and colonisation with antibiotic-resistant bacteria. METHODS: For this systematic review and meta-analysis, we searched PubMed, the Cochrane Database of Systematic Reviews, the Cochrane Central Register of Controlled Trials, and Web of Science for studies published from Jan 1, 1960, to May 31, 2016, that analysed the effect of antibiotic stewardship programmes on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infections in hospital inpatients. Two authors independently assessed the eligibility of trials and extracted data. Studies involving long-term care facilities were excluded. The main outcomes were incidence ratios (IRs) of target infections and colonisation per 1000 patient-days before and after implementation of antibiotic stewardship. Meta-analyses were done with random-effect models and heterogeneity was calculated with the I2 method. FINDINGS: We included 32 studies in the meta-analysis, comprising 9 056 241 patient-days and 159 estimates of IRs. Antibiotic stewardship programmes reduced the incidence of infections and colonisation with multidrug-resistant Gram-negative bacteria (51% reduction; IR 0·49, 95% CI 0·35-0·68; p<0·0001), extended-spectrum β-lactamase-producing Gram-negative bacteria (48%; 0·52, 0·27-0·98; p=0·0428), and meticillin-resistant Staphylococcus aureus (37%; 0·63, 0·45-0·88; p=0·0065), as well as the incidence of C difficile infections (32%; 0·68, 0·53-0·88; p=0·0029). Antibiotic stewardship programmes were more effective when implemented with infection control measures (IR 0·69, 0·54-0·88; p=0·0030), especially hand-hygiene interventions (0·34, 0·21-0·54; p<0·0001), than when implemented alone. Antibiotic stewardship did not affect the IRs of vancomycin-resistant enterococci and quinolone-resistant and aminoglycoside-resistant Gram-negative bacteria. Significant heterogeneity between studies was detected, which was partly explained by the type of interventions and co-resistance patterns of the target bacteria. INTERPRETATION: Antibiotic stewardship programmes significantly reduce the incidence of infections and colonisation with antibiotic-resistant bacteria and C difficile infections in hospital inpatients. These results provide stakeholders and policy makers with evidence for implementation of antibiotic stewardship interventions to reduce the burden of infections from antibiotic-resistant bacteria. FUNDING: German Center for Infection Research.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Baur D, Gladstone BP, Burkert F, et al. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. Lancet Infect Dis. 2017. PMID: 28629876. doi:10.1016/S1473-3099(17)30325-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。